Coupang impresses, stock market steady, earnings roll on, and more… ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Want to Receive Free Daily Insights? |
| We get it — the stock market moves fast, and it can be hard to keep up. That’s why we created Breakfast News, your daily dose of expert market analysis, actionable tips, and Foolish fun, all delivered straight to your inbox every morning. Consider this a sneak peek at the kind of insights and updates you can expect, and what thousands of investors rely on every morning to stay ahead of the market. And the best part? It’s completely free to receive every market day. The only catch? Today’s email is just a preview; you have to opt in by clicking the button below to get these insights delivered daily — so you’re always prepared before the market opens. |
|
|
| S&P 500 5,783 (+1.23%) Nasdaq 18,439 (+1.43%) Dow 42,222 (+1.02%) Bitcoin 69,532 (+3.54%) |
|
|
|
|
|
|
|
|
|
|
|
Coupang (NYSE:CPNG) beat estimates yesterday, as Fool analyst Alicia Alfiere noted management "reached its goal of bringing Farfetch close to breakeven adjusted EBITDA profitability and accomplished this goal earlier than expected – which is impressive." |
| Q3 revenue soared 63% year-over-year: Medical devices specialist Globus (NYSE:GMED) also posted beats, with earnings per share (EPS) gaining 46%. Bright biotech outlook: Gene-editing researcher CRISPR Therapeutics (NASDAQ:CRSP) missed Q3 revenue estimates, as investors expect the launch of key new drug Casgevy to boost the final quarter. |
|
|
2. Stocks Move Up And to the Right
|
| Andy Cross speaks: “Political concerns inevitably seem more pressing as a fiercely contested presidential race resulted in a projected victory for Republican nominee Donald Trump. Here’s the real truth: For investing, it doesn’t matter much.” “Over time, the real winner is the long-term investor”: Remember our Foolish core investing tenets, including (but not limited to) save and invest, rinse and repeat. Take advantage of market volatility by looking for buying opportunities. And most importantly, stay in the game. |
|
|
An update from energy drinks maker Celsius (NASDAQ:CELH) is due before the market opens today, with customer relationship technologist HubSpot (NYSE:HUBS) due to post after the close. |
| Beating Monster?: Investors will be looking to see how Celsius can take market share from Monster Beverage (NASDAQ:MNST) and from Red Bull. Eyes on earnings: After a Q2 beat on the back of strong revenue growth, shareholder focus will be shifting to HubSpot’s earnings prospects as the company previously posted upbeat full-year guidance. |
|
|
4. More Companies Set To Report |
MercadoLibre (NASDAQ:MELI) is due to post Q3 results at 5:00 p.m. ET. The stock has gained 50% in the past 12 months, and is up 7,141% since IPO in 2007. |
| What to expect: The “Amazon (NASDAQ: AMZN) of Latin America” has Mexico in its growth sights, as it continues to develop AI-powered tools to answer product questions. Cosmetics boost: Up 500% in 5 years, e.l.f. Beauty (NYSE:ELF) reports after the bell. Last quarter, Fool analyst Sanmeet Deo called out how "they are outshining competitors with jaw-dropping market share gains. They're now the #2 cosmetics brand in the U.S., doubling their share in just three years." |
| e.l.f. Beauty stock is up 300%+ since its mid-2022 inflection. It's a brand many investors have never heard of, yet it's wildly popular with Gen Z. What other brands or technologies do you keep hearing from young people in your life that could inspire a worthwhile investment? Discuss with friends and family, or become a member to hear what your fellow Fools are saying! |
|
|
You can start your day ahead of the game with the market’s top stories and key investing insights by subscribing to the Fool’s Breakfast News email. Just click below — it’s free! |
|
|
How did you like this email? |
If you have any questions, check out our Help Center here. The Motley Fool, its directors, employees, contractors or staff may own positions in the companies mentioned in this email. For more details, please see our disclosure policy. The Motley Fool
2000 Duke Street
Alexandria, VA 22314 Manage your email settings. Copyright 2024 The Motley Fool. All rights reserved. |
|
|
|
